The National Audit of Primary Breast Cancer (NAoPri), part of the National Cancer Audit Collaborating Centre (NATCAN), has published a State of the Nation 2024 report on the care received by people diagnosed with primary breast cancer during 2019-21 in England and Wales. Based on data relating to 130,300 people, this report is the audit’s first annual assessment of NHS breast services and provides a baseline description of care.
It reports on indicators that were defined to monitor progress against the following five NAoPri quality improvement goals:
- Improve the movement of patients through the care pathway
- Reduce unwarranted variation for patients undergoing surgery
- Reduce unwarranted variation for patients having non-surgical oncological treatments
- Improve access to breast reconstruction after mastectomy
- Improve and reduce unwarranted variation in primary breast cancer outcomes.
The report also contains five recommendations:
- Ensure that people with breast cancer have access to Triple Diagnostic Assessment (TDA) in a single visit
- Review the use of neo-adjuvant chemotherapy for all patients with early invasive breast cancer to reduce levels of unexplained regional variation
- Confirm breast multidisciplinary teams (MDT) have a data lead responsible for ensuring the quality of national data submissions
- Ensure the recording of date and type of breast cancer recurrence in cancer datasets
- Review rates of immediate reconstruction and, where rates are identified as below the mean, act to improve access to immediate reconstruction.
This report was originally published on 12th September 2024. This is version 2: October 2024 – This version of the report includes corrections in the infographic on page 6, in audit statistics on page 7, and in paragraph 3 of page 12. The second paragraph of the key messages on page 12 has been reworded for clarity and statistics have been updated.
Read the full report: You can view the report by clicking the button below.
Stay up-to-date: For notifications of future reports from HQIP, sign up to our mailing list.